Last year, when the US Food and Drug Administration asked Merck and the other manufacturers of bisphosphonate drugs to warn patients about the risk of developing osteonecrosis of the jaw while taking fosamax medications, many did not realize the true implications of it.

Now that Parker & Waichman, LLP, a leader in defective pharmaceutical litigation has come forward to file lawsuits on behalf of patients diagnosed with Osteonecrosis of the Jaw, American citizens started showing their interest which quickly turned to sympathy and support to the unfortunate victims.

The story goes like this:
Fosamax is the medication given to patients who are afflicted with osteoporosis, a disease of bone in which the bone mineral density (BMD) is reduced. Mostly women who have passed menopause are affected by this disease.

It is believed that Fosamax and other similar bisphosphonate drugs may cause osteonecrosis of the jaw by blocking the normal reproduction of bone cells.

The American Dental Association (ADA) also recommends that patients tell their physicians and dentists that they are taking bisphosphonate medications before any dental work is performed.

But osteonecrosis stuck many people who have taken fosamax and
Parker & Waichman, LLP was contacted by hundreds of victims of fosamax related side effects.

For more information on Parker & Waichman, LLP, please visit: YourLawyer.com or call (800) LAW-INFO